UCM logo

Uscom Limited Stock Price

ASX:UCM Community·AU$3.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

UCM Share Price Performance

AU$0.012
-0.02 (-62.50%)
AU$0.012
-0.02 (-62.50%)
Price AU$0.012

UCM Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk and slightly overvalued.

6 Risks
0 Rewards

Uscom Limited Key Details

AU$2.6m

Revenue

AU$348.7k

Cost of Revenue

AU$2.2m

Gross Profit

AU$5.5m

Other Expenses

-AU$3.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.013
86.48%
-128.07%
-4,117.9%
View Full Analysis

About UCM

Founded
1999
Employees
n/a
CEO
Robert Phillips
WebsiteView website
www.uscom.com.au

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm. The company also provides the SpiroSonic Ultrasonic spirometer, a pulmonary function testing device that uses multi-path ultrasound; SpiroSonic FLO and SpiroSonic AIR, a digital multi-path ultrasonic spirometer for pulmonary function diagnostic and monitoring COPD and asthma; and SpiroSonic SMART for use by general practitioners and patients for screening COPD and asthma. It serves hospitals and medical care locations through its distribution partners. The company was formerly known as Uscom Pty Limited and changed its name to Uscom Limited in October 2003. The company was incorporated in 1999 and is headquartered in Sydney, Australia.

Recent UCM News & Updates

Recent updates

No updates